Showing 15 posts of 884 posts found.

Valneva and Pfizer share positive results from phase 2 trial for Lyme disease vaccine candidate

September 7, 2023
Medical Communications Infections and infestations, Pfizer, Vaccine, Valneva, clinical trial, lyme disease

Valneva and Pfizer have announced positive paediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, …

FDA approves Pfizer’s vaccine for the prevention of RSV in children

August 22, 2023
Research and Development FDA, Paediatrics, Pfizer, RSV

On Monday, Pfizer announced that the US Food and Drug Administration (FDA) has approved Abrysvo for the prevention of respiratory …

FDA grants accelerated approval to Pfizer’s Elrexfio

August 15, 2023
Medical Communications Elrexfio, FDA, Oncology, Pfizer, accelerated approval

Pfizer has that the US Food and Drug Administration (FDA) has granted accelerated approval to Elrexfio (elranatamab-bcmm) for the treatment …


AstraZeneca’s Alexion partners with Pfizer for rare disease therapies

July 28, 2023
Research and Development Alexion, AstraZeneca, Pfizer, Rare Diseases, genomics, rare disease

Alexion, AstraZeneca’s Rare Disease division, has announced that it has entered a definitive purchase and licence agreement with Pfizer. The …

Vaccine image

Pfizer shares new data from phase 2 trial for GBS maternal vaccine candidate

July 20, 2023
Research and Development Immunology, Pfizer, Vaccine, clinical trial

Pfizer has announced new data from its phase 2 study which assessed its hexavalent capsular polysaccharide (CPS) conjugate Group B …

CellCentric announces $25m investment from Pfizer

July 12, 2023
Business Services Cancer, CellCentric, Oncology, Pfizer, collaboration, investment

UK-based biotechnology company CellCentric has announced a strategic investment from Pfizer including $25m to finance further development of inobrodib, its …

FDA approves Pfizer’s Litfulo for patients with severe alopecia areata

June 26, 2023
Medical Communications FDA, Litfulo, Pfizer, Pharmacy, alopecia, alopecia areata

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its Litfulo (ritlecitinib) for patients over the …


FDA approves Pfizer’s HRR mCRPC drug

June 21, 2023
Medical Communications FDA, Oncology, Pfizer, breast cancer, oncology, prostate cancer

US-based pharmaceutical and biotechnology company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its homologous …

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

June 2, 2023
Medical Communications NHS, NICE, Neurology, Pfizer, migraine

The National Institute for Health and Care Excellence (NICE) has announced that it has recommended an oral treatment for the …

FDA approves Pfizer’s RSV vaccine for older adults

June 1, 2023
Research and Development FDA, Infections and infestations, Pfizer, RSV, Vaccine

Global pharmaceutical company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its respiratory syncytial virus …


FDA committee votes in favour of Pfizer’s RSV vaccine for maternal immunisation

May 19, 2023
Research and Development FDA, Immunology, Pfizer, RSV, Vaccine, maternal immunisation

Pfizer has announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) from the US Food and Drug Administration …

Thermo Fisher and Pfizer collaborate on NGS-based cancer tests

May 10, 2023
Medical Communications Cancer, NGS, Oncology, Pfizer, Thermo Fisher Scientifitic, oncology

Scientific equipment provider Thermo Fisher and US pharmaceutical firm Pfizer have announced a collaboration to advance next-generation sequencing (NGS)-based cancer …


FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children

April 28, 2023
Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021
Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …


Moderna and Pfizer COVID-19 vaccine protection declines over time

September 16, 2021
Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

Latest content